Cyclerion Therapeutics (CYCN) Other Gross PP&E Adjustments (2018 - 2025)
Cyclerion Therapeutics has reported Other Gross PP&E Adjustments over the past 8 years, most recently at -$143000.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 52.13% year-over-year to -$143000.0; the TTM value through Sep 2025 reached -$23000.0, up 83.21%, while the annual FY2025 figure was -$143000.0, 52.13% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$143000.0 at Cyclerion Therapeutics, down from -$23000.0 in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $909000.0 in Q1 2022 and troughed at -$40.7 million in Q1 2021.
- A 5-year average of -$3.3 million and a median of -$140000.0 in 2024 define the central range for Other Gross PP&E Adjustments.
- Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 107.97% in 2022 and later tumbled 481.01% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$6.8 million in 2021, then fell by 8.07% to -$7.4 million in 2022, then grew by 6.03% to -$6.9 million in 2023, then skyrocketed by 98.65% to -$94000.0 in 2024, then crashed by 52.13% to -$143000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CYCN at -$143000.0 in Q4 2025, -$23000.0 in Q3 2025, and -$80000.0 in Q2 2025.